Search

everythinglearnresearchcommunity

for

Search:↓

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Different botulinum toxin products and concentrations can effectively reduce sweating, itching, bladder pressure, hair loss, and muscle spasms.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Long-term diabetes is linked to lower prostate cancer risk.

Apoptosis, not oxidative stress, is linked to aging in mice with mtDNA mutations.

New gene mutations linked to skin conditions were found, bacteria and chemicals may worsen acne, a dog mutation could exist in humans, virus-like elements might be involved in psoriasis, and a vitamin D3 treatment doesn't prevent chemotherapy-related hair loss.

Genetic factors play a major role in acne.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Lasers are effective for some skin conditions but can cause side effects like scarring and pigment changes; careful selection is important, and botulinum toxin type A is successful in reducing sweat in palmar hyperhidrosis.

The document concludes that there is a need for more research and regulation in dermatology, covering topics like latex allergy in children, the use of botulinum toxin, and treatments for skin conditions.

The document concludes that misdiagnosis in skin conditions is common, certain treatments can cause allergic reactions, and some skin symptoms are linked to leukemia, especially in certain Japanese regions.

The document summarizes skin and immune system disease findings, especially related to AIDS, from the 1980s.

Stem cell treatments show promise for hair loss but need more research.

Androgenic alopecia in men is mainly linked to family history, hormonal imbalances, and metabolic issues, but can also be influenced by lifestyle habits, environmental factors, and deficiencies in certain vitamins and microelements like copper.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Finasteride increases risk of depression, possibly suicidal thoughts, and sexual dysfunction.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

Topical minoxidil 1% and 2% are twice as effective as placebo for female pattern hair loss.

DA-9401 protects against hair loss, improves organ function, and prevents infertility caused by finasteride.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

Finasteride for hair loss can cause erectile dysfunction due to tissue fibrosis.

Finasteride for hair loss may cause erectile dysfunction due to tissue fibrosis, and various factors contribute to female sexual dysfunction.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Finasteride 5mg/day improves hair loss in normoandrogenic Asian women.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Finasteride effectively treats mild to moderate hair loss in men aged 18-41, with some side effects.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.